BAKARDJIEVA, Marina, PELÁK, Ondřej, WENTINK, Marjolein W.J, GLIER, Hana, NOVÁK, David, STANČÍKOVÁ, Jitka, KUŽÍLKOVÁ, Daniela, MEJSTRIKOVA, Ester, JANOWSKA, Iga, RIZZI, Marta, BURG, Mirjam van der, STUCHLY, Jan und KALINA, Tomas, 2024. Tviblindi algorithm identifies branching developmental trajectories of human B‐cell development and describes abnormalities in RAG‐1 and WAS patients. Freiburg: Universität.
Elsevier - Harvard (with titles)Bakardjieva, M., Pelák, O., Wentink, M.W., Glier, H., Novák, D., Stančíková, J., Kužílková, D., Mejstrikova, E., Janowska, I., Rizzi, M., Burg, M. van der, Stuchly, J., Kalina, T., 2024. Tviblindi algorithm identifies branching developmental trajectories of human B‐cell development and describes abnormalities in RAG‐1 and WAS patients. Universität, Freiburg. https://doi.org/10.1002/eji.202451004
American Psychological Association 7th editionBakardjieva, M., Pelák, O., Wentink, M. W., Glier, H., Novák, D., Stančíková, J., Kužílková, D., Mejstrikova, E., Janowska, I., Rizzi, M., Burg, M. van der, Stuchly, J., & Kalina, T. (ca. 2024). Tviblindi algorithm identifies branching developmental trajectories of human B‐cell development and describes abnormalities in RAG‐1 and WAS patients [Cd]. Universität. https://doi.org/10.1002/eji.202451004
Springer - Basic (author-date)Bakardjieva M, Pelák O, Wentink MW, Glier H, Novák D, Stančíková J, Kužílková D, Mejstrikova E, Janowska I, Rizzi M, Burg M van der, Stuchly J, Kalina T (2024) Tviblindi algorithm identifies branching developmental trajectories of human B‐cell development and describes abnormalities in RAG‐1 and WAS patients. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Bakardjieva, Marina/ Pelák, Ondřej/ Wentink, Marjolein W.J/ Glier, Hana/ Novák, David/ Stančíková, Jitka/ Kužílková, Daniela/ Mejstrikova, Ester/ Janowska, Iga/ Rizzi, Marta/ Burg, Mirjam van der/ Stuchly, Jan/ Kalina, Tomas, Tviblindi algorithm identifies branching developmental trajectories of human B‐cell development and describes abnormalities in RAG‐1 and WAS patients, Freiburg 2024.